Exploring antibiotic resistance mechanisms in Mycobacterium abscessus for enhanced therapeutic approaches

Front Microbiol. 2024 Feb 6:15:1331508. doi: 10.3389/fmicb.2024.1331508. eCollection 2024.

Abstract

Mycobacterium abscessus, a leading cause of severe lung infections in immunocompromised individuals, poses significant challenges for current therapeutic strategies due to resistance mechanisms. Therefore, understanding the intrinsic and acquired antibiotic resistance of M. abscessus is crucial for effective treatment. This review highlights the mechanisms employed by M. abscessus to sustain antibiotic resistance, encompassing not only conventional drugs but also newly discovered drug candidates. This comprehensive analysis aims to identify novel entities capable of overcoming the notorious resistance exhibited by M. abscessus, providing insights for the development of more effective therapeutic interventions.

Keywords: Mycobacterium abscessus; drug resistance; efflux pump; intrinsic-extrinsic drug resistance; mycobacterium drug efficacy.

Publication types

  • Review

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This work is supported by a grant of the Ministry of Health & Welfare, Republic of Korea (HI22C136100 and 2020ER520601), funded by the grant 2020R1A2C100407714 and RS-2023-00266419 from the National Research Foundation (NRF) of Republic of Korea. This research was also supported by “Regional Innovation Strategy (RIS)” through the NRF funded by the Ministry of Education (MOE) (2021RIS001, 1345370811). TN, BH, SJ, and AA were supported by the BK21 Four Program. AA was sponsored by the Global Korea Scholarship program under the MOE in Korea.